Differential effects of 5-HT(1B/1D) receptor agonists on neurogenic dural plasma extravasation and vasodilation in anaesthetized rats

Neuropharmacology

Volumn 36, Issue 4-5, 1997, Pages 525-533

  Shepherd, S L ^a   Williamson, D J ^a   Beer, M S ^a   Hill, R G ^a   Hargreaves, R J ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

5 HT(1B) receptor; 5 HT(1D) receptor; CP 122 288; CP 93 129; Dura; Migraine; Sumatriptan

Indexed keywords

3 (1,2,5,6 TETRAHYDRO 4 PYRIDYL)PYRROLO[3,2 B]PYRIDIN 5 ONE; 5 METHYLAMINOSULFONYLMETHYL 3 (1 METHYL 2 PYRROLIDINYLMETHYL) 1H INDOLE; BOVINE SERUM ALBUMIN; RECEPTOR SUBTYPE; SEROTONIN 1B AGONIST; SEROTONIN 1B RECEPTOR; SEROTONIN 1D AGONIST; SEROTONIN 1D RECEPTOR; SEROTONIN AGONIST; SERUM ALBUMIN I 125; SUMATRIPTAN; UNCLASSIFIED DRUG;

AFFERENT NERVE GROUP 1; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHO CELL; CONTROLLED STUDY; DRUG POTENCY; DURA MATER; ELECTROSTIMULATION; EXTRAVASATION; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; MICROSCOPY; MIGRAINE; NERVE FIBER C; NEUROGENIC INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SENSORY NERVE; TRIGEMINUS GANGLION; VASODILATATION;

ANESTHESIA, GENERAL; ANIMALS; BLOOD PROTEINS; CAPILLARY PERMEABILITY; DURA MATER; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HELA CELLS; HUMANS; MALE; PYRIDINES; PYRROLES; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SEROTONIN AGONISTS; SUMATRIPTAN; VASODILATION;

EID: 0030941211     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)00057-9     Document Type: Article

References (40)

1. Beattie D. T. and Connor H. E. (1995) The pre- and post-junctional activity of CP-122 288, a conformationally restricted analogue of sumatriptan. European Journal of Pharmacology 276: 271-276.
2. Bouchelet I., Cohen Z., Case B., Seguela P. and Hamel E. (1996) Differential expression of sumatriptan-senstive 5-hydroxytryptamine receptors in human trigeminal ganglia and cererbal blood vessels. Molecular Pharmacology 60: 219-223.
3. 1B receptor messenger RNA in rat brain and trigeminal ganglia. British Journal of Pharmacology 108: 95.
4. Buzzi M. G. and Moskowitz M. A. (1990) The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. British Journal of Pharmacology 99: 202-206.
5. Buzzi M. G., Carter W. B., Shimizu T., Heath III H. and Moskowitz M. A. (1991a) Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior saggital sinus during electrical stimulation of the trigeminal ganglion. Neuropharmacology 30: 1193-1200.
6. Buzzi M. G., Moskowitz M. A., Peroutka S. J. and Byun B. (1991b) Further characterisation of the receptor which mediated blockade of neurogenic plasma extravasation in rat dura mater. British Journal of Pharmacology 103: 1421-1428.
7. Cullen B. R. (1987) Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods in Enzymology 152: 684-704.
8. Diener H. C. for the RPR100893-201 migraine study group (1995) Substance-P antagonist RPR100893-201 is not effective in human migraine atacks. 6th International Headache Research Seminar, 17-19 November 1995, Copenhagen, Denmark.
9. 1-like receptor agonist, for the acute treatment of severe migraine. Lancet i: 1309-1311.
10. Edvinsson L., Brodin E., Jansen I. and Uddman R. (1988) Neurokinin A in cerebral vessels: characterization, localisation and effects in vitro. Regulating Peptides 20: 181-197.
11. 1B receptor on CHO cells: functional responses in the absence of radioligand binding. British Journal of Pharmacology 117: 119-1126.
12. (8.37) antagonizes the cerebral vasodilator response from nasociliary nerve stimulation in the cat. Neuroscience Letters 151: 13-16.
13. Goadsby P. J. and Edvinsson L. (1993) The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Annals of Neurology 33: 48-56.
14. Goadsby P. J., Edvinsson L. and Ekman R. (1988) Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Annals of Neurology 23: 193-196.
15. Goldstein D. (1996) Clinical trials of tachykinin antagonists. Conference on Tachykinins and their Antagonists, 10-11 October 1996, London, U.K.
16. 1 receptor agonist CP-122 288, a selective inhibitor of neurogenic inflammation. British Journal of Pharmacology 116: 2385-2390.
17. Hanesch U., Moussaoui S. and Schmidt R. F. (1995) Substance P and its receptor NK-1 in rat dura mater encephali - an immunocytochemical study. Social Neuroscience Abstracts 21: 1115.
18. 1D receptor subtypes. Trends in Pharmacological Science 17: 103-107.
19. Humphrey P. P. A. and Feniuk W. (1991) Mode of action of the anti-migraine drug sumatriptan. Trends in Pharmacological Science 12: 444-446.
20. Janig W. and Lisney S. J. W. (1989) Small diameter myelinated afferents produce vasodilation but not plasma extravasation in rat skin. Journal of Physiology 415: 477-486.
21. Jansen I., Alafaci C., McCulloch J., Uddman R. and Edvinsson L. (1991) Tachykinins (substance P, neurokinin A, neuropeptide K and neurokinin B) in the cerebral circulation: vasomotor responses in vitro and in situ. Journal of Cerebral Blood Flow Metabolism 11: 567-575.
22. Jansen I., Uddmann R., Ekman R., Olesen J., Ottosson A. and Edvinsson L. (1992a) Distribution and effects of neuropeptide Y, vasoactive intestinal polypeptide, substance P and calcitonin gene-related peptide in human middle meningeal arteries: comparison with cerebral and temporal arteries. Peptides 13: 527-536.
23. 1-like receptor. Cephalalgia 12: 202-205.
24. 1 receptor agonist, CP-122 288, on oedema formation induced by stimulation of the rat saphenous nerve. British Journal of Pharmacology 115: 1-2.
25. Kurosawa M., Messlinger K., Pawlak M. and Schmidt R. F. (1995) Increase of meningeal blood flow after electrical stimulation of rat dura mater encephali: mediation by calcitonin gene-related peptide. British Journal of Pharmacology 114: 1397-1402.
26. 35S]-GTPyS binding mediated by human muscarinic m1-m4 receptors: antagonist studies. British Journal of Pharmacology 109: 1120-1127.
27. Lee W. S. and Moskowitz M. A. (1993) Conformationally restricted analogues, CP-122 288 and CP-122 638 exhibit enhanced potency against neurogenic inflammation in dura mater. Brain Research 626: 303-305.
28. Lee Y., Kawai Y., Shiosaka S., Takami K., Kiyama H., Hillyard C. J., Girgis S., MacIntyre I., Emson P. C. and Tohyama M. (1985) Coexisitence of calcitonin gene-related peptide and substance P-like peptide in single cells of the trigeminal ganglion of the rat: immunohistochemical analysis. Brain Research 330: 194-196.
29. Markowitz S., Saito K. and Moskowitz M. A. (1987) Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. Journal of Neuroscience 7: 4129-4136.
30. 1B receptor agonist blocks neurogenic plasma extravasation within rat but not guinea pig dura mater. British Journal of Pharmacology 104: 3-4.
31. McCarthy P. W. and Lawson S. N. (1990) Cell type and conduction velocity of rat primary sensory neurons with calcitonin gene-related peptide-like immunoreactivity. Neuroscience 34: 623-632.
32. McCulloch J., Uddman R., Kingman T. A. and Edvinsson L. (1986) Calcitonin gene-related peptide: functional role in cerebrovascular regulation. Proceedings of the National Academy of Science U.S.A. 83: 5731-5735.
33. Moskowitz M. A. (1992) Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends in Pharmacological Science 13: 307-311.
34. Nissila M., Parkkola R., Sonninen P. and Salonen R. (1996) Intracerebral arteries and gadolinium enhancement in migraine without aura, 11th Migraine Trust International Symposium, 9-12 September 1996, London, U.K.
35. O'Connor T. P. and van der Kooy D. (1988) Enrichment of a vasoactive neuropeptide (calcitonin gene-related peptide) in the trigeminal sensory projection to the intracranial arteries. Journal of Neuroscience 8: 2468-2476.
36. 1 receptor antagonists RP67580 blocks neurogenic plasma extravasation in the dura mater of rats. British Journal of Pharmacology 108: 11-12.
37. 1 antagonist CP-99 994 on plasma extravasation in dura mater and c-fos mRNA expression in the trigeminal nucleus caudalis of rats. Neuropharmacology 34: 255-261.
38. Strassman A. M., Raymond S. A. and Burnstein R. (1996) Sensitization of meningeal sensory neurons and the origin of headaches. Nature 384: 560-564.
39. Williamson D. J., Hargreaves R. J., Hill R. G. and Shepheard S. L. (1996) Direct measurement of dural blood vessel diameter in the rat using intravital microscopy. British Journal of Pharmacology 117: 271.
40. 1B receptors. Molecular Pharmacology 49: 761-765.